Keloid

Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting

Retrieved on: 
Wednesday, March 13, 2024

BOCA RATON, Fla., March 13, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces the successful launch of its new “Fair Deal Agreement” for the SRT-100 Vision™ (IG-SRT) at the AAD 2024 Annual Meeting, held March 8-12 in San Diego. This meeting is the largest gathering of dermatologists in the U.S., hosting more than 10,000 medical personnel at this year’s event.

Key Points: 
  • This meeting is the largest gathering of dermatologists in the U.S., hosting more than 10,000 medical personnel at this year’s event.
  • Sensus manufactures and sells the only proven, FDA-cleared IG-SRT system and holds a patent for SRT combined with ultrasound, which is deeper and more effective.
  • “The AAD Annual Meeting was the ideal forum to launch our new Fair Deal Agreement program, and the response among conference attendees exceeded our most optimistic expectations.
  • This technology is ideal for better managing dermatology clinical practice, and is a Sensus Healthcare exclusive.

What are ‘collarium’ sunbeds? Here’s why you should stay away

Retrieved on: 
Wednesday, February 14, 2024

A collarium sunbed emits both UV radiation and a mix of visible wavelength colours to produce a pink or red light.

Key Points: 
  • A collarium sunbed emits both UV radiation and a mix of visible wavelength colours to produce a pink or red light.
  • Like an old-school sunbed, the user lies in it for ten to 20 minute sessions to quickly develop a tan.

Why were sunbeds banned?

  • Commercial sunbeds have been illegal across Australia since 2016 (except for in the Northern Territory) under state-based radiation safety laws.
  • Their dangers were highlighted by young Australians including Clare Oliver who developed melanoma after using sunbeds.
  • Research shows people who have used sunbeds at least once have a 41% increased risk of developing melanoma, while ten or more sunbed sessions led to a 100% increased risk.

How are collarium sunbeds supposed to be different?

  • Australian sellers of collarium sunbeds imply they are safe, but their machine descriptions note the use of UV radiation, particularly UVA.
  • UVA is one part of the spectrum of UV radiation.
  • Evidence shows all types of sunbeds increase the risk of melanoma, including those that use only UVA.

Collagen claims

  • One particularly odd claim about collarium sunbeds is that they stimulate collagen.
  • Collagen is the main supportive tissue in our skin.
  • The reactive oxygen species generated by UVA light damage existing collagen structures and kick off a molecular chain of events that downgrades collagen-producing enzymes and increases collagen-destroying enzymes.
  • Over time, a build-up of degraded collagen fragments in the skin promotes even more destruction.

What about phototherapy?

  • The anti-collagen effects of UVA can also be used to treat thickened scars and keloids.
  • Side-effects of UV phototherapy include tanning, itchiness, dryness, cold sore virus reactivation and, notably, premature skin ageing.

So what happens now?

  • It looks like many collariums are just sunbeds rebranded with red light.
  • Queensland Health is currently investigating whether these salons are breaching the state’s Radiation Safety Act, and operators could face large fines.


Katie Lee receives funding from the National Health and Medical Research Council. Anne Cust receives funding from the National Health and Medical Research Council and Medical Research Future Fund.

Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Thursday, February 8, 2024

BOCA RATON, Fla., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial results for the three and 12 months ended December 31, 2023.

Key Points: 
  • Revenues for the fourth quarter of 2023 were $12.6 million, compared with $13.1 million for the fourth quarter of 2022.
  • Cost of sales was $4.7 million for the fourth quarter of 2023, compared with $4.8 million for the prior-year quarter.
  • General and administrative expense was $1.0 million for the fourth quarter of 2023, compared with $1.4 million for the fourth quarter of 2022.
  • Adjusted EBITDA for the fourth quarter of 2023 was $5.7 million, compared with $4.3 million for the fourth quarter of 2022.

Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements

Retrieved on: 
Tuesday, February 6, 2024

BOCA RATON, Fla., Feb. 06, 2024 (GLOBE NEWSWIRE) --  Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces a new multi-faceted collaboration with CureRays, a radiation oncology specialist organization based in Atlanta and Grass Valley, Calif. 

Key Points: 
  • Under the collaboration, CureRays will provide Sensus’ dermatology customers with oversight and supervision to assure patient safety, quality, reliability of outcomes and conformance with regulatory requirements, in particular in states where regulations covering the use of ionizing radiation have been tightened.
  • In addition, CureRays will research new indications for Sensus’ superficial radiotherapy (SRT and IG-SRT), including inflammatory diseases.
  • We were anxious to help stem fatalities in any way we could, and we’ve been impressed with their commitment to patient care.
  • My goal is also to help further enhance patient selection against the risks and benefits of radiotherapy.”

Sensus Healthcare to Participate in the Roth MKM 2023 Healthcare Opportunities Conference and the 43rd Annual Fall Clinical Dermatology Conference

Retrieved on: 
Monday, October 9, 2023

Sensus management will also participate in the 43rd Annual Fall Clinical Dermatology Conference being held October 19-22, 2023 at the Wynn Hotel in Las Vegas.

Key Points: 
  • Sensus management will also participate in the 43rd Annual Fall Clinical Dermatology Conference being held October 19-22, 2023 at the Wynn Hotel in Las Vegas.
  • Joe Sardano, chairman and chief executive officer of Sensus Healthcare, will deliver a 10-minute presentation at 11:15 a.m. Eastern time at the Yale Club.
  • To request a meeting with Sensus Healthcare management, please contact your Roth MKM representative or Kim Golodetz at LHA Investor Relations at [email protected] .
  • To schedule an appointment or for more information about Sensus Healthcare's participation, please contact Sensus Healthcare by visiting www.sensushealthcare.com .

Sensus Healthcare to Showcase its Full Line of Cutting-Edge Superficial Radiotherapy Devices for the Treatment of Non-melanoma Skin Cancer at ASTRO 2023 in San Diego

Retrieved on: 
Tuesday, September 26, 2023

Leveraging this esteemed event, Sensus Healthcare is set to present its full line of state-of-the-art superficial radiotherapy (SRT) devices for the treatment of non-melanoma skin cancer and keloids to hospital administrators and radiation oncologists from around the world.

Key Points: 
  • Leveraging this esteemed event, Sensus Healthcare is set to present its full line of state-of-the-art superficial radiotherapy (SRT) devices for the treatment of non-melanoma skin cancer and keloids to hospital administrators and radiation oncologists from around the world.
  • ASTRO is the premier gathering of radiation oncology professionals, where industry leaders converge to discuss breakthrough technologies and cutting-edge treatment methodologies.
  • Sensus Healthcare's devices utilize the Multi-Dimensional Superficial Radiotherapy platform, which provides an alternative low-energy X-ray treatment for various types of non-melanoma skin cancer and keloids.
  • To schedule an appointment or for more information about Sensus Healthcare's participation, please contact Sensus Healthcare by visiting www.sensushealthcare.com.

Sensus Healthcare Partners with MIS Healthcare to Distribute SRT Systems in the United Kingdom and Ireland

Retrieved on: 
Thursday, July 6, 2023

BOCA RATON, Fla, July 06, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces a partnership with MIS Healthcare to distribute Sensus’ superficial radiation therapy (SRT) products in the United Kingdom and Ireland.

Key Points: 
  • BOCA RATON, Fla, July 06, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces a partnership with MIS Healthcare to distribute Sensus’ superficial radiation therapy (SRT) products in the United Kingdom and Ireland.
  • This agreement includes the company’s SRT-100™, SRT-100+™ and SRT-100 Vision™ systems for the treatment of non-melanoma skin cancer and keloids.
  • “Our new partnership with MIS Healthcare provides Sensus with greater exposure in the United Kingdom and Ireland, and opens new markets for our SRT products.
  • Each day nearly 600 people are diagnosed with non-melanoma skin cancer in the United Kingdom and Ireland.

$21.2 Billion Worldwide Scar Treatment Industry to 2027: Featuring Alliance Pharma, AVITA Medical, Cutera and GC Aesthetics Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, January 27, 2023

Scar treatment refers to the techniques and procedures employed for the remedy of acne, keloid, contracture, hypertrophic scars, etc.

Key Points: 
  • Scar treatment refers to the techniques and procedures employed for the remedy of acne, keloid, contracture, hypertrophic scars, etc.
  • The treatment and revision procedures are employed to minimize the appearance of these scars so that they look more consistent with the surrounding skin tone and texture.
  • The growing aesthetic sense among the masses has led to the widespread adoption of skin treatment procedures.
  • Our report has categorized the market based on product or treatment type, scar type and end-user.

Sensus Healthcare to Host Third Quarter 2022 Financial Results and Business Update Conference Call on November 3, 2022

Retrieved on: 
Thursday, October 27, 2022

In addition, management will provide a business update and a discussion on recent and upcoming milestones.

Key Points: 
  • In addition, management will provide a business update and a discussion on recent and upcoming milestones.
  • To access the conference call, the dial-in numbers are 866-777-2509 (U.S. and Canada Toll Free), 412-317-5413 (International).
  • Please direct the operator to be connected to the Sensus Healthcare conference call.
  • Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for both oncological and non-oncological conditions.

Sensus Healthcare Introduces Silk™ Laser Hair Removal System

Retrieved on: 
Thursday, October 20, 2022

Silk by Sensus features a truly portable diode laser with 2000W power, a lightweight handpiece, super-cold cooling tip and high repetition rates.

Key Points: 
  • Silk by Sensus features a truly portable diode laser with 2000W power, a lightweight handpiece, super-cold cooling tip and high repetition rates.
  • Importantly, the laser is sensitive to all skin types, making laser hair removal available to everyone.
  • With its unique combination of optimized energy distribution, versatility, speed, comfort and efficacy, we believe that Silk by Sensus introduces a new standard in laser hair removal.
  • Silk by Sensus permits full hair removal on any part of the body.